March 1, 2017  
eSequence
HELP FUND ACGT CANCER RESEARCH ON MARCH  9

Sponsored by Fairfield County Community Foundation(FCCF), Giving Day  is a 24-hour on-line opportunity to make special donations to local organizations making a real difference. The event celebrates the work of local nonprofits to help those most in need and to forge a path to safer healthier futures. Last year, $1.25 million was raised for 410 organizations. Every dollar counts on this day and every gift to ACGT helps us qualify for additional funding through the FCCF.
 
You too can make a real difference - mark 3.09.17 on your calendar to support ACGT  and Fairfield County. Be sure to visit the Fairfield County Giving Day  site and click the "Other" Category to donate to the ACGT page designated for this event. Thank you in advance for your support.
 
2017 ACGT YOUNG INVESTIGATOR: GREG DELGOFFE, PhD
Assistant Professor, Immunology, University of Pittsburgh School of Medicine

Cancer immunotherapy has been scoring great wins as an alternative or adjunct to chemotherapy, especially with blood cancers. Many patients are in remission because of this revolutionary gene therapy. Using a simple blood draw and cell engineering technology, scientists like Dr. Delgoffe are able to awaken the body's immune system to destroy cancers. However, cancer is adept at hiding from the immune system and this has been a critical obstacle to broader practice, particularly with solid cancers like melanoma. Dr. Delgoffe plans to deplete nutrients tied to immune-suppressors in order to bypass the evasion mechanism.
 
"The goal is to generate super-soldier T cells to be redirected to the tumor site, while bolstered metabolically to support long-term and durable responses."
 
Dr. Delgoffe earned a PhD at Johns Hopkins University School of Medicine and a BS in Biomedical Sciences at Western Michigan University, and has published several papers in the field of immune metabolism and tumor immunology. In 2015, Delgoffe  was selected as a Kimmel Scholar by the Sidney Kimmel Foundation for Cancer Research.
 
ACGT 's Young Investigator Award for Cell and Gene Therapy for Cancer grants up to $250,000 over two-three years to tenure-track assistant professors working in dedicated research institutes in the U.S. and Canada.
 
ACGT ANNIVERSARY GALA APRIL 19

Dr. John Lahey
At the ACGT Gala on Wednesday, April 19th, at The Harvard Club of New York City, ACGT will present the first Edward Netter Award for Business to John Lahey, PhD, President, Quinnipiac University, Hamden, Connecticut. Dr. Lahey, who has served on ACGT's Board since 2004, embodies the qualities our co-founder valued most: intellect, tenacity, creativity, curiosity and compassion.
 
Gala speakers also include: ACGT Research Fellow, Dr. Robert Vonderheide, University of Pennsylvania, who will share news about immunotherapy for pancreatic cancer and solid tumors; and Doug Olson, one of the first participants in Dr. Carl June's groundbreaking immunotherapy trial for chronic lymphocytic leukemia.
 
Join us to celebrate revolutionary cancer treatments. Tickets can be purchased online, or by contacting Barbara Gallagher, National Director of Philanthropy. Consider supporting the event as a sponsor or underwriter to help us pave the way to more cancer research success. Contact Barbara Gallagher for more information.

RESEARCH IS THE ANSWER TO CANCER
 
Join the Fight - Donate to ACGT
2017 ACGT CLINICAL INVESTIGATOR AWARD
REQUEST FOR APPLICATIONS  Letter of Intent deadline March 21

ACGT's Clinical Investigator Award is now open and accepting letters of intent from tenure-track or tenured faculty conducting original, independent research in cancer cell and gene therapy leading directly to clinical translation. The grant recipient will receive up to $500,000 over 2-3 years, inclusive of a maximum of 10% indirect costs.

Our Scientific Advisory Council reviews all full applications and makes its recommendation to the Board of Directors. Learn more here.

JUNE 24, 2017 - SAVE THE DATE
GREENWICH-STAMFORD SWIM ACROSS AMERICA FOR ACGT

Swim Across America LogoA decade long and still swimming strong, ACGT l ooks forward to hosting the next decade of Swim Across America events with this year's Greenwich-Stamford Swim on Saturday June 24th. Over $3 million has been raised to-date to support innovative cell, gene and immunotherapy research for cancer. Each year, roughly 250 swimmers and boaters of all ages from many Fairfield and Westchester County communities, take the plunge to honor friends and loved ones and cancer survivors.

Event chairs Michele Graham and Lorrie Lorenz, both parents of cancer survivors, invite you to join in the day's event as a sponsor, swimmer and/or volunteer. Contact Barbara Gallagher, N ational Director of Philanthropy, or click here to sign-up or donate.

STANFORD UNIVERSITY SHEDS NEW LIGHT ON PRECISION MEDICINE FOR CANCER

At a first-time symposium at Stanford University's new Center for Definitive and Curative Medicine, researchers described the progress and promise of cell and gene therapies to deal with a long list of diseases, with the ultimate goal to "create one-time treatments that can provide lifetime cures." Scientists reported on replacing cells in the cornea, advancing bone marrow transplants without toxic drugs, generating new beta cells for Type 1 diabetes, and using immunology for cancer to outsmart the cancer.
 
"We are at the end of the beginning," said Dr. Crystal Mackall, a cancer immunotherapy expert and the recipient of the 2016 ACGT Wendy-Walk/Swim Across America Sarcoma grant.

ACGT is the only non-profit organization in the nation dedicated exclusively to funding  cell and gene therapies for cancer. Since its founding in 2001, ACGT has awarded  52 gr ants totaling nearly $27 million in North America, and continues to be a catalyst for cell and gene therapy research.
 
100% of all donations are used to support ACGT research grants and studies in cell and gene therapies for cancer.

Share our hope and share our dedication to more effective ways of targeting cancer .
Please forward this email to anyone whose life has been touched by cancer. 
 
Keep posted on progress at www.acgtfoundation.org, or Facebook, Twitter and Linkedin.